Analysen von Keyur Parekh
| 14.06.18 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 13.06.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 13.06.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 30.05.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 30.05.18 | Bayer buy | Goldman Sachs Group Inc. | |
| 29.05.18 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 29.05.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.05.18 | MorphoSys Neutral | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 22.05.18 | Merck Neutral | Goldman Sachs Group Inc. | |
| 22.05.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 18.05.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 15.05.18 | Merck Neutral | Goldman Sachs Group Inc. | |
| 08.05.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.05.18 | Bayer buy | Goldman Sachs Group Inc. | |
| 08.05.18 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 03.05.18 | Bayer buy | Goldman Sachs Group Inc. | |
| 03.05.18 | MorphoSys Neutral | Goldman Sachs Group Inc. | |
| 03.05.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.05.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 30.04.18 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 27.04.18 | Bayer buy | Goldman Sachs Group Inc. | |
| 26.04.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.04.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 18.04.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 18.04.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.04.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 27.03.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 26.03.18 | GSK buy | Goldman Sachs Group Inc. | |
| 23.03.18 | GSK buy | Goldman Sachs Group Inc. | |
| 22.03.18 | Bayer buy | Goldman Sachs Group Inc. | |
| 21.03.18 | Merck Neutral | Goldman Sachs Group Inc. | |
| 20.03.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.03.18 | MorphoSys Neutral | Goldman Sachs Group Inc. | |
| 13.03.18 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 13.03.18 | MorphoSys Neutral | Goldman Sachs Group Inc. | |
| 09.03.18 | Merck Neutral | Goldman Sachs Group Inc. | |
| 08.03.18 | MorphoSys Neutral | Goldman Sachs Group Inc. | |
| 06.03.18 | Bayer buy | Goldman Sachs Group Inc. | |
| 02.03.18 | GSK buy | Goldman Sachs Group Inc. | |
| 02.03.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 02.03.18 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 02.03.18 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 02.03.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 28.02.18 | Bayer buy | Goldman Sachs Group Inc. | |
| 22.02.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.02.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.02.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 12.02.18 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 08.02.18 | GSK buy | Goldman Sachs Group Inc. | |
| 07.02.18 | Sanofi Neutral | Goldman Sachs Group Inc. | |